Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

Interferon-stimulated gene 15 pathway is a novel mediator of endothelial dysfunction and aneurysms development in angiotensin II infused mice through increased oxidative stress.

  • González-Amor, María
  • García-Redondo, Ana B
  • Jorge, Inmaculada
  • Zalba, Guillermo
  • Becares, Martina
  • Ruiz-Rodríguez, María J
  • Rodríguez, Cristina
  • Bermeo, Hugo
  • Rodrigues-Díez, Raquel
  • Rios, Francisco J
  • Montezano, Augusto C
  • Martínez-González, Jose
  • Vázquez, Jesús
  • Redondo, Juan Miguel
  • Touyz, Rhian M
  • Guerra, Susana
  • Salaices, Mercedes
  • Briones, Ana M
Interferon-stimulated gene 15 (ISG15) encodes a ubiquitin-like protein that induces a reversible post-translational modification (ISGylation) and can also be secreted as a free form. ISG15 plays an essential role as host-defence response to microbial infection; however, its contribution to vascular damage associated with hypertension is unknown. Bioinformatics identified ISG15 as a mediator of hypertension-associated vascular damage. ISG15 expression positively correlated with systolic and diastolic blood pressure and carotid intima-media thickness in human peripheral blood mononuclear cells. Consistently, Isg15 expression was enhanced in aorta from hypertension models and in angiotensin II (AngII)-treated vascular cells and macrophages. Proteomics revealed differential expression of proteins implicated in cardiovascular function, extracellular matrix and remodelling, and vascular redox state in aorta from AngII-infused ISG15-/- mice. Moreover, ISG15-/- mice were protected against AngII-induced hypertension, vascular stiffness, elastin remodelling, endothelial dysfunction, and expression of inflammatory and oxidative stress markers. Conversely, mice with excessive ISGylation (USP18C61A) show enhanced AngII-induced hypertension, vascular fibrosis, inflammation and reactive oxygen species (ROS) generation along with elastin breaks, aortic dilation, and rupture. Accordingly, human and murine abdominal aortic aneurysms showed augmented ISG15 expression. Mechanistically, ISG15 induces vascular ROS production, while antioxidant treatment prevented ISG15-induced endothelial dysfunction and vascular remodelling. ISG15 is a novel mediator of vascular damage in hypertension through oxidative stress and inflammation.
Repisalud
Publicación Artículo científico (JournalArticle)

Rolipram Prevents the Formation of Abdominal Aortic Aneurysm (AAA) in Mice: PDE4B as a Target in AAA

  • Varona, Saray
  • Puertas, Lídia
  • Galán, María
  • Orriols, Mar
  • Cañes, Laia
  • Aguiló, Silvia
  • Camacho, Mercedes
  • Sirvent, Marc
  • Andres, Vicente
  • Martinez-Gonzalez, Jose
  • Rodriguez, Cristina
Abdominal aortic aneurysm (AAA) is a common life-threatening condition characterized by exacerbated inflammation and the generation of reactive oxygen species. Pharmacological treatments to slow AAA progression or to prevent its rupture remain a challenge. Targeting phosphodiesterase 4 (PDE4) has been verified as an effective therapeutic strategy for an array of inflammatory conditions; however, no studies have assessed yet PDE4 in AAA. Here, we used angiotensin II (AngII)-infused apolipoprotein E deficient mice to study the involvement of the PDE4 subfamily in aneurysmal disease. PDE4B but not PDE4D was upregulated in inflammatory cells from both experimental and human AAA. The administration of the PDE4 selective inhibitor rolipram (3 mg/kg/day) to AngII-challenged mice (1000 ng/kg bodyweight/min) protected against AAA formation, limiting the progressive increase in the aortic diameter without affecting the blood pressure. The drug strongly attenuated the rise in vascular oxidative stress (superoxide anion) induced by AngII, and decreased the expression of inflammatory markers, as well as the recruitment of macrophages (MAC3+), lymphocytes (CD3+), and neutrophils (ELANE+) into the vessel wall. Rolipram also normalized the vascular MMP2 expression and MMP activity, preserving the elastin integrity and improving the vascular remodelling. These results point to PDE4B as a new therapeutic target for AAA. View Full-Text
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Proteine Bolognese

  • Cubarsi, R.
  • Vázquez, E.
  • Villaverde, A.
[EN] The penetration of a modified version of a green fluorescent protein called GFP in the cytoplasm and nucleus of a mammalian cell is modelled. The mathematical model provides a first approach to the experiment, with a progressive decreasing rate of fluorescence as the total luminosity increases until saturation. However, a local deviation from the proposed model is detected, due to a process that takes place in a non-differentiable way. The phenomenon is explained from the sudden entrance of GFP into the cytoplasm and nucleus by the weakening or permeabilization of their membranes, and from the obstruction of GFP flux by the nuclear membrane. Thus, the mathematical model provides relevant information on the deviation from the pattern that has been adopted. To unify the European Higher Education Area (EHEA), and in accordance with the guidelines of the Bologna Process, the subjects of new curricula have under- gone a thorough review of their contents. So the new methodology be fruitful, a highly optimized agenda must be designed by linking every topic with topics from other subjects. The case presented evidences how Mathematical Modelling is useful to implement and review lessons learned in various subjects, from maths and biology in the current case, besides being an effective way to stimulate learning, since it is showing the usefulness of what is studied., [ES] Se modeliza la penetración de una versión modificada de la proteína verde fluorescente llamada GFP en el citoplasma y el núcleo de una célula de mamífero. El modelo matemático proporciona una primera aproximación al experimento, con una disminución progresiva de la tasa de fluorescencia a medida que la luminosidad total va aumentando hasta saturarse. Sin embargo, se detecta una desviación localizada del modelo propuesto, debida a un proceso que no se realiza de forma totalmente diferenciable. El fenómeno es explicable a partir de la irrupción brusca de GFP en el citoplasma y el núcleo por la debilitación o permeabilización de sus membranas, y por la obstrucción del flujo de GFP por la membrana nuclear. El modelo matemático proporciona pues información relevante sobre la desviación del patrón que se ha adoptado. Con la finalidad de unificar del Espacio Europeo de Educación Superior (EEES), y de acuerdo con las directrices del Proceso de Bolonia, las asignaturas de los nuevos planes de estudios han sufrido una re- visión a fondo de sus contenidos. Para que la nueva metodología de sus frutos, es necesario diseñar un temario muy optimizado, en el que cada tema entronque con temas de otras asignaturas. El caso presentado evidencia como la Modelización Matemática es útil para aplicar y revisar los conocimientos adquiridos en diversas asignaturas, de matemáticas y biología en este caso, además de ser una forma eficaz de estimular el aprendizaje, ya que muestra la utilidad de lo que se estudia., Agradecemos el apoyo financiero recibido de MICINN (ACI2009-0919),FISS (PS0900165), AGAUR (2009SGR-108) y el CIBER de Bioingeniería, Biomateriales y Nanomedicina. AV ha sido distinguido con un premio ICREA ACADEMIA.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Opposite effects of moderate and extreme Cx43 deficiency in conditional Cx43-deficient mice on angiotensin II-induced cardiac fibrosis

  • Valls de Lacalle, Laura
  • Negre Pujol, Corall
  • Varona, Saray
  • Valera Cañellas, Antoni
  • Consegal Perez, Marta
  • Rodríguez Sinovas, Antonio
  • Rodriguez, Cristina
Angiotensin II; Fibrosis; Collagen, Angiotensina II; Fibrosi; Col·lagen, Angiotensina II; Fibrosis; Colágeno, Connexin 43 (Cx43) is essential for cardiac electrical coupling, but its effects on myocardial fibrosis is controversial. Here, we analyzed the role of Cx43 in myocardial fibrosis caused by angiotensin II (AngII) using Cx43fl/fl and Cx43Cre-ER(T)/fl inducible knock-out (Cx43 content: 50%) mice treated with vehicle or 4-hydroxytamoxifen (4-OHT) to induce a Cre-ER(T)-mediated global deletion of the Cx43 floxed allele. Myocardial collagen content was enhanced by AngII in all groups (n = 8–10/group, p < 0.05). However, animals with partial Cx43 deficiency (vehicle-treated Cx43Cre-ER(T)/fl) had a significantly higher AngII-induced collagen accumulation that reverted when treated with 4-OHT, which abolished Cx43 expression. The exaggerated fibrotic response to AngII in partially deficient Cx43Cre-ER(T)/fl mice was associated with enhanced p38 MAPK activation and was not evident in Cx43 heterozygous (Cx43+/-) mice. In contrast, normalization of interstitial collagen in 4-OHT-treated Cx43Cre-ER(T)/fl animals correlated with enhanced MMP-9 activity, IL-6 and NOX2 mRNA expression, and macrophage content, and with reduced α-SMA and SM22α in isolated fibroblasts. In conclusion, our data demonstrates an exaggerated, p38 MAPK-dependent, fibrotic response to AngII in partially deficient Cx43Cre-ER(T)/fl mice, and a paradoxical normalization of collagen deposition in animals with an almost complete Cx43 ablation, an effect associated with increased MMP-9 activity and inflammatory response and reduced fibroblasts differentiation., This work was supported by Fundació La Marató de TV3 (nº. 201536-10), the Spanish Instituto de Salud Carlos III (grants PI18/0919 and CIBERCV) and Ministerio de Ciencia, Innovación y Universidades (grant RTI2018-094727-B-100), cofinanced by the European Regional Development Fund (ERDF-FEDER, a way to build Europe), and Agencia de Gestió d’Ajuts Universitaris i de Recerca (AGAUR; program of Support to Research Groups, Refs. 2017-SGR-1807 and 2017-SGR-00333). Antonio Rodríguez-Sinovas has a consolidated Miguel Servet contract.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Comparative analysis of lentiviral vectors and modular protein nanovectors for traumatic brain injury gene therapy

  • Negro-Demontel, María Luciana
  • Saccardo, Paolo|||0000-0002-3092-1404
  • Giacomini, Cecilia
  • Yáñez-Muñoz, Rafael J.|||0000-0001-7113-1938
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
Traumatic brain injury (TBI) remains as one of the leading causes of mortality and morbidity worldwide and there are no effective treatments currently available. Gene therapy applications have emerged as important alternatives for the treatment of diverse nervous system injuries. New strategies are evolving with the notion that each particular pathological condition may require a specific vector. Moreover, the lack of detailed comparative studies between different vectors under similar conditions hampers the selection of an ideal vector for a given pathological condition. The potential use of lentiviral vectors versus several modular protein-based nanovectors was compared using a controlled cortical impact model of TBI under the same gene therapy conditions. We show that variables such as protein/DNA ratio, incubation volume, and presence of serum or chloroquine in the transfection medium impact on both nanovector formation and transfection efficiency in vitro. While lentiviral vectors showed GFP protein 1 day after TBI and increased expression at 14 days, nanovectors showed stable and lower GFP transgene expression from 1 to 14 days. No toxicity after TBI by any of the vectors was observed as determined by resulting levels of IL-1β or using neurological sticky tape test. In fact, both vector types induced functional improvement per se.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Engineering protein self-assembling in protein-based nanomedicines for drug delivery and gene therapy

  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Rodríguez-Carmona, Escarlata
  • Corchero Nieto, José Luis|||0000-0002-6109-144X
  • Garcia-Fruitos, Elena|||0000-0001-7498-4864
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
Lack of targeting and improper biodistribution are major flaws in current drug-based therapies that prevent reaching high local concentrations of the therapeutic agent. Such weaknesses impose the administration of high drug doses, resulting in undesired side effects, limited efficacy and enhanced production costs. Currently, missing nanosized containers, functionalized for specific cell targeting will be then highly convenient for the controlled delivery of both conventional and innovative drugs. In an attempt to fill this gap, health-focused nanotechnologies have put under screening a growing spectrum of materials as potential components of nanocages, whose properties can be tuned during fabrication. However, most of these materials pose severe biocompatibility concerns. We review in this study how proteins, the most versatile functional macromolecules, can be conveniently exploited and adapted by conventional genetic engineering as efficient building blocks of fully compatible nanoparticles for drug delivery and how selected biological activities can be recruited to mimic viral behavior during infection. Although engineering of protein self-assembling is still excluded from fully rational approaches, the exploitation of protein nano-assemblies occurring in nature and the direct manipulation of protein-protein contacts in bioinspired constructs open intriguing possibilities for further development. These methodologies empower the construction of new and potent vehicles that offer promise as true artificial viruses for efficient and safe nanomedical applications.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Engineering building blocks for self-assembling protein nanoparticles

  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
Like natural viruses, manmade protein cages for drug delivery are to be ideally formed by repetitive subunits with self-assembling properties, mimicking viral functions and molecular organization. Naturally formed nanostructures (such as viruses, flagella or simpler protein oligomers) can be engineered to acquire specific traits of interest in biomedicine, for instance through the addition of cell targeting agents for desired biodistribution and specific delivery of associated drugs. However, fully artificial constructs would be highly desirable regarding finest tuning and adaptation to precise therapeutic purposes. Although engineering of protein assembling is still in its infancy, arising principles and promising strategies of protein manipulation point out the rational construction of nanoscale protein cages as a feasible concept, reachable through conventional recombinant DNA technologies and microbial protein production.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Post-production protein stability, trouble beyond the cell factory

  • Vázquez, Esther|||0000-0003-1052-0424
  • Corchero Nieto, José Luis|||0000-0002-6109-144X
  • Villaverde, Antonio|||0000-0002-2615-4521
Being protein function a conformation-dependent issue, avoiding aggregation during production is a major challenge in biotechnological processes, what is often successfully addressed by convenient upstream, midstream or downstream approaches. Even when obtained in soluble forms, proteins tend to aggregate, especially if stored and manipulated at high concentrations, as is the case of protein drugs for human therapy. Post-production protein aggregation is then a major concern in the pharmaceutical industry, as protein stability, pharmacokinetics, bioavailability, immunogenicity and side effects are largely dependent on the extent of aggregates formation. Apart from acting at the formulation level, the recombinant nature of protein drugs allows intervening at upstream stages through protein engineering, to produce analogue protein versions with higher stability and enhanced therapeutic values.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Co-production of GroELS discriminates between intrinsic and thermally-induced recombinant protein aggregation during substrate quality control

  • Platas, Gemma
  • Rodríguez-Carmona, Escarlata
  • Garcia-Fruitos, Elena|||0000-0001-7498-4864
  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Villaverde, Antonio|||0000-0002-2615-4521
The effects and effectiveness of the chaperone pair GroELS on the yield and quality of recombinant polypeptides produced in Escherichia coli are matter of controversy, as the reported activities of this complex are not always consistent and eventually indicate undesired side effects. The divergence in the reported data could be due, at least partially, to different experimental conditions in independent research approaches. We have then selected two structurally different model proteins (namely GFP and E. coli β-galactosidase) and two derived aggregation-prone fusions to explore, in a systematic way, the eventual effects of GroELS co-production on yield, solubility and conformational quality. Host cells were cultured at two alternative temperatures below the threshold at which thermal stress is expected to be triggered, to minimize the involvement of independent stress factors. From the analysis of protein yield, solubility and biological activity of the four model proteins produced alone or along the chaperones, we conclude that GroELS impacts on yield and quality of aggregation-prone proteins with intrinsic determinants but not on thermally induced protein aggregation. No effective modifications of protein solubility have been observed, but significant stabilization of small (encapsulable) substrates and moderate chaperone-induced degradation of larger (excluded) polypeptides. These findings indicate that the activities of this chaperone pair in the context of actively producing recombinant bacteria discriminate between intrinsic and thermally-induced protein aggregation, and that the side effects of GroELS overproduction might be determined by substrate size.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Biological activities of histidine-rich peptides, merging biotechnology and nanomedicine

  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Corchero Nieto, José Luis|||0000-0002-6109-144X
  • Kumar, Pradeep
  • Cedano, Juan|||0000-0003-1380-8036
  • Gupta, Kailash C..
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
Histidine-rich peptides are commonly used in recombinant protein production as purification tags, allowing the one-step affinity separation of the His-tagged proteins from the extracellular media or cell extracts. Genetic engineering makes feasible the post-purification His-tag removal by inserting, between the tag and the main protein body, a target site for trans-acting proteases or a self-proteolytic peptide with regulatable activities. However, for technical ease, His tags are often not removed and the fusion proteins eventually used in this form. In this commentary, we revise the powerful biological properties of histidine-rich peptides as endosomolytic agents and as architectonic tags in nanoparticle formation, for which they are exploited in drug delivery and other nanomedical applications. These activities, generally unknown to biotechnologists, can unwillingly modulate the functionality and biotechnological performance of recombinant proteins in which they remain trivially attached.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Intracellular CXCR4 + cell targeting with T22-empowered protein-only nanoparticles

  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Cedano, Juan|||0000-0003-1380-8036
  • Corchero Nieto, José Luis|||0000-0002-6109-144X
  • Domingo-Espin, Joan|||0000-0001-8149-0803
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Mangues, Ramon|||0000-0003-2661-9525
  • Vázquez, Esther|||0000-0003-1052-0424
Cell-targeting peptides or proteins are appealing tools in nanomedicine and innovative medicines because they increase the local drug concentration and reduce potential side effects. CXC chemokine receptor 4 (CXCR4) is a cell surface marker associated with several severe human pathologies, including colorectal cancer, for which intracellular targeting agents are currently missing. Four different peptides that bind CXCR4 were tested for their ability to internalize a green fluorescent protein-based reporter nanoparticle into CXCR4 + cells. Among them, only the 18 mer peptide T22, an engineered segment derivative of polyphemusin II from the horseshoe crab, efficiently penetrated target cells via a rapid, receptor-specific endosomal route. This resulted in accumulation of the reporter nanoparticle in a fully fluorescent and stable form in the perinuclear region of the target cells, without toxicity either in cell culture or in an in vivo model of metastatic colorectal cancer. Given the urgent demand for targeting agents in the research, diagnosis, and treatment of CXCR4-linked diseases, including colorectal cancer and human immunodeficiency virus infection, T22 appears to be a promising tag for the intracellular delivery of protein drugs, nanoparticles, and imaging agents.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Emerging Roles of Lysyl Oxidases in the Cardiovascular System, New Concepts and Therapeutic Challenges

  • Martínez-González, José|||0000-0002-3894-7166
  • Varona, Saray|||0000-0002-7375-313X
  • Cañes Esteve, Laia|||0000-0002-9579-1321
  • Galán, María|||0000-0002-4758-8388
  • Briones, Ana|||0000-0001-8218-5579
  • Cachofeiro, Victoria
  • Rodríguez, Cristina|||0000-0002-6472-5647
Lysyl oxidases (LOX and LOX-likes (LOXLs) isoenzymes) belong to a family of copper-dependent enzymes classically involved in the covalent cross-linking of collagen and elastin, a pivotal process that ensures extracellular matrix (ECM) stability and provides the tensile and elastic characteristics of connective tissues. Besides this structural role, in the last years, novel biological properties have been attributed to these enzymes, which can critically influence cardiovascular function. LOX and LOXLs control cell proliferation, migration, adhesion, differentiation, oxidative stress, and transcriptional regulation and, thereby, their dysregulation has been linked to a myriad of cardiovascular pathologies. Lysyl oxidase could modulate virtually all stages of the atherosclerotic process, from endothelial dysfunction and plaque progression to calcification and rupture of advanced and complicated plaques, and contributes to vascular stiffness in hypertension. The alteration of LOX/LOXLs expression underlies the development of other vascular pathologies characterized by a destructive remodeling of the ECM, such as aneurysm and artery dissections, and contributes to the adverse myocardial remodeling and dysfunction in hypertension, myocardial infarction, and obesity. This review examines the most recent advances in the study of LOX and LOXLs biology and their pathophysiological role in cardiovascular diseases with special emphasis on their potential as therapeutic targets.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Nr4a3, A key nuclear receptor in vascular biology, cardiovascular remodeling and beyond

  • Martínez-González, José|||0000-0002-3894-7166
  • Cañes Esteve, Laia|||0000-0002-9579-1321
  • Alonso Nieto, Judith|||0000-0003-0537-0417
  • Ballester-Servera, Carme|||0000-0001-7858-3064
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
  • Corrales Insa, Irene|||0000-0002-0647-0340
  • Rodríguez, Cristina|||0000-0002-6472-5647
The mechanisms committed in the activation and response of vascular and inflammatory immune cells play a major role in tissue remodeling in cardiovascular diseases (CVDs) such as atherosclerosis, pulmonary arterial hypertension, and abdominal aortic aneurysm. Cardiovascular remodeling entails interrelated cellular processes (proliferation, survival/apoptosis, inflammation, extracellular matrix (ECM) synthesis/degradation, redox homeostasis, etc.) coordinately regulated by a reduced number of transcription factors. Nuclear receptors of the subfamily 4 group A (NR4A) have recently emerged as key master genes in multiple cellular processes and vital functions of different organs, and have been involved in a variety of high-incidence human pathologies including atherosclerosis and other CVDs. This paper reviews the major findings involving NR4A3 (Neuron-derived Orphan Receptor 1, NOR-1) in the cardiovascular remodeling operating in these diseases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Rolipram prevents the formation of abdominal aortic aneurysm (Aaa) in mice, pde4b as a target in AAA

  • Varona, Saray|||0000-0002-7375-313X
  • Puertas Umbert, Lídia|||0000-0002-2739-6522
  • Galán, María|||0000-0002-4758-8388
  • Orriols, Mar
  • Cañes Esteve, Laia|||0000-0002-9579-1321
  • Aguiló, Silvia|||0000-0003-0672-8388
  • Camacho, Mercedes|||0000-0001-5970-3294
  • Sirvent, M.
  • Andrés, Vicente|||0000-0002-0125-7209
  • Martínez-González, José|||0000-0002-3894-7166
  • Rodríguez, Cristina|||0000-0002-6472-5647
Abdominal aortic aneurysm (AAA) is a common life-threatening condition characterized by exacerbated inflammation and the generation of reactive oxygen species. Pharmacological treatments to slow AAA progression or to prevent its rupture remain a challenge. Targeting phosphodiesterase 4 (PDE4) has been verified as an effective therapeutic strategy for an array of inflammatory conditions; however, no studies have assessed yet PDE4 in AAA. Here, we used angiotensin II (AngII)-infused apolipoprotein E deficient mice to study the involvement of the PDE4 subfamily in aneurysmal disease. PDE4B but not PDE4D was upregulated in inflammatory cells from both experimental and human AAA. The administration of the PDE4 selective inhibitor rolipram (3 mg/kg/day) to AngII-challenged mice (1000 ng/kg bodyweight/min) protected against AAA formation, limiting the progressive increase in the aortic diameter without affecting the blood pressure. The drug strongly attenuated the rise in vascular oxidative stress (superoxide anion) induced by AngII, and decreased the expression of inflammatory markers, as well as the recruitment of macrophages (MAC3+), lymphocytes (CD3+), and neutrophils (ELANE+) into the vessel wall. Rolipram also normalized the vascular MMP2 expression and MMP activity, preserving the elastin integrity and improving the vascular remodelling. These results point to PDE4B as a new therapeutic target for AAA.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

CD69-oxLDL ligand engagement induces Programmed Cell Death 1 (PD-1) expression in human CD4 + T lymphocytes

  • Jiménez-Fernández, María
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Cañes Esteve, Laia|||0000-0002-9579-1321
  • Ballester-Servera, Carme|||0000-0001-7858-3064
  • Vara, Alicia
  • Requena, Silvia
  • Fuente, Hortensia de la
  • Martínez-González, José|||0000-0002-3894-7166
  • Sánchez-Madrid, Francisco|||0000-0001-5303-0762
The mechanisms that control the inflammatory-immune response play a key role in tissue remodelling in cardiovascular diseases. T cell activation receptor CD69 binds to oxidized low-density lipoprotein (oxLDL), inducing the expression of anti-inflammatory NR4A nuclear receptors and modulating inflammation in atherosclerosis. To understand the downstream T cell responses triggered by the CD69-oxLDL binding, we incubated CD69-expressing Jurkat T cells with oxLDL. RNA sequencing revealed a differential gene expression profile dependent on the presence of CD69 and the degree of LDL oxidation. CD69-oxLDL binding induced the expression of NR4A receptors (NR4A1 and NR4A3), but also of PD-1. These results were confirmed using oxLDL and a monoclonal antibody against CD69 in CD69-expressing Jurkat and primary CD4 + lymphocytes. CD69-mediated induction of PD-1 and NR4A3 was dependent on NFAT activation. Silencing NR4A3 slightly increased PD-1 levels, suggesting a potential regulation of PD-1 by this receptor. Moreover, expression of PD-1, CD69 and NR4A3 was increased in human arteries with chronic inflammation compared to healthy controls, with a strong correlation between PD-1 and CD69 mRNA expression (r = 0.655 P < 0.0001). Moreover, PD-1 was expressed in areas enriched in CD3 infiltrating T cells. Our results underscore a novel mechanism of PD-1 induction independent of TCR signalling that might contribute to the role of CD69 in the modulation of inflammation and vascular remodelling in cardiovascular diseases.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Opposite effects of moderate and extreme Cx43 deficiency in conditional Cx43-deficient mice on angiotensin II-induced cardiac fibrosis

  • Valls de Lacalle, Laura
  • Negre Pujol, Corall
  • Varona, Saray
  • Valera Cañellas, Antoni
  • Consegal Perez, Marta
  • Rodríguez Sinovas, Antonio
  • Rodriguez, Cristina
Angiotensin II; Fibrosis; Collagen, Angiotensina II; Fibrosi; Col·lagen, Angiotensina II; Fibrosis; Colágeno, Connexin 43 (Cx43) is essential for cardiac electrical coupling, but its effects on myocardial fibrosis is controversial. Here, we analyzed the role of Cx43 in myocardial fibrosis caused by angiotensin II (AngII) using Cx43fl/fl and Cx43Cre-ER(T)/fl inducible knock-out (Cx43 content: 50%) mice treated with vehicle or 4-hydroxytamoxifen (4-OHT) to induce a Cre-ER(T)-mediated global deletion of the Cx43 floxed allele. Myocardial collagen content was enhanced by AngII in all groups (n = 8–10/group, p < 0.05). However, animals with partial Cx43 deficiency (vehicle-treated Cx43Cre-ER(T)/fl) had a significantly higher AngII-induced collagen accumulation that reverted when treated with 4-OHT, which abolished Cx43 expression. The exaggerated fibrotic response to AngII in partially deficient Cx43Cre-ER(T)/fl mice was associated with enhanced p38 MAPK activation and was not evident in Cx43 heterozygous (Cx43+/-) mice. In contrast, normalization of interstitial collagen in 4-OHT-treated Cx43Cre-ER(T)/fl animals correlated with enhanced MMP-9 activity, IL-6 and NOX2 mRNA expression, and macrophage content, and with reduced α-SMA and SM22α in isolated fibroblasts. In conclusion, our data demonstrates an exaggerated, p38 MAPK-dependent, fibrotic response to AngII in partially deficient Cx43Cre-ER(T)/fl mice, and a paradoxical normalization of collagen deposition in animals with an almost complete Cx43 ablation, an effect associated with increased MMP-9 activity and inflammatory response and reduced fibroblasts differentiation., This work was supported by Fundació La Marató de TV3 (nº. 201536-10), the Spanish Instituto de Salud Carlos III (grants PI18/0919 and CIBERCV) and Ministerio de Ciencia, Innovación y Universidades (grant RTI2018-094727-B-100), cofinanced by the European Regional Development Fund (ERDF-FEDER, a way to build Europe), and Agencia de Gestió d’Ajuts Universitaris i de Recerca (AGAUR; program of Support to Research Groups, Refs. 2017-SGR-1807 and 2017-SGR-00333). Antonio Rodríguez-Sinovas has a consolidated Miguel Servet contract.